Core Viewpoint - *ST Ningke is a significant player in the domestic long-chain dicarboxylic acid sector, facing challenges in revenue and profitability compared to industry peers [1][2][3]. Financial Performance - In Q3 2025, *ST Ningke reported revenue of 327 million yuan, ranking 70th among 79 companies in the industry, with the industry leader, Sinochem International, generating 35.716 billion yuan [2]. - The company's net profit for the same period was a loss of 282 million yuan, placing it 78th in the industry, while the top performer, Hangyang Co., reported a net profit of 850 million yuan [2]. Financial Ratios - As of Q3 2025, *ST Ningke's debt-to-asset ratio was 101.86%, significantly higher than the industry average of 34.74% [3]. - The company's gross margin was -25.18%, which is below the industry average of 19.93% [3]. Corporate Governance - The chairman, Fu Jie, and the general manager, Zhu Canti, received a total compensation of 301,000 yuan for the year 2024 [4]. - The controlling shareholder is Shanghai Zhongneng Enterprise Development (Group) Co., Ltd., with Yu Jianming as the actual controller [4]. Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 4.84% to 17,600, while the average number of circulating A-shares held per shareholder increased by 5.09% to 39,000 [5].
*ST宁科的前世今生：2025年三季度营收3.27亿远低于行业平均，净利润亏损2.82亿排名垫底
Xin Lang Cai Jing·2025-10-30 16:01